Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143026
Status:
COMPLETED
Last Update Posted:
2017-03-29
First Post:
2005-08-31
Brief Title:
Study to Compare the Effect of Treatment With CarbidopaLevodopaEntacapone on the Quality of Life of Patients With Parkinsons Disease This Study is Not Recruiting in the United States
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Study to Compare the Effect of Treatment With CarbidopaLevodopaEntacapone on the Quality of Life of Patients With Parkinsons Disease
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines the effect of treatment of levodopaentacapone on quality of life as measured by the Parkinsons Disease-Questionnaire 8 PDQ-8 in Parkinsons disease patients with no or minimal non-disabling motor fluctuations
Detailed Description:
This study examines the effect of treatment of levodopaentacapone on quality of life as measured by the Parkinsons Disease-Questionnaire 8 PDQ-8 in Parkinsons disease patients with no or minimal non-disabling motor fluctuations Treatment with carbidopalevodopaentacapone will be compared with treatment with standard formulation levodopacarbidopa
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None